Get started
Keyword

FOLFIRINOX

Description: A combination chemotherapy regimen of folinic acid, fluorouracil, irinotecan, and oxaliplatin, used especially to treat pancreatic cancer.
Wikidata ID: wiki/Q17144959
OpenAlex ID: keywords/folfirinox
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 · Thierry Conroy, Françoise Desseigne, et al. · New England Journal of Medicine · 7,800
PDF
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
2018 · Thierry Conroy, Pascal Hammel, et al. · New England Journal of Medicine · 2,863
PDF
Pancreatic cancer
2020 · Jonathan D Mizrahi, Rishi Surana, et al. · The Lancet · 2,542
Pancreatic cancer
2016 · Terumi Kamisawa, Laura D Wood, et al. · The Lancet · 2,209
Pancreatic Cancer
2021 · Wungki Park, Akhil Chawla, et al. · JAMA · 1,893
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
2021 · Thierry Conroy, Jean-François Bosset, et al. · The Lancet Oncology · 1,348
Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
2014 · Cristina R. Ferrone, Giovanni Marchegiani, et al. · Annals of Surgery · 845
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
2016 · Timothy M Nywening, Andrea Wang-Gillam, et al. · The Lancet Oncology · 810
Chemoresistance in Pancreatic Cancer
2019 · Siyuan Zeng, Marina Pöttler, et al. · International Journal of Molecular Sciences · 612
PDF
Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
2015 · Ignacio Garrido-Laguna, Manuel Hidalgo · Nature Reviews Clinical Oncology · 565
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma
2018 · Janet E. Murphy, Jennifer Y. Wo, et al. · JAMA Oncology · 531
PDF
Locally Advanced Pancreatic Cancer
2016 · Thilo Hackert, Milena Sachsenmaier, et al. · Annals of Surgery · 529
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
2019 · Janet E. Murphy, Jennifer Y. Wo, et al. · JAMA Oncology · 523
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
2014 · Manuel Hidalgo, Stefano Cascinu, et al. · Pancreatology · 509
PDF
Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
2012 · Sophie Gourgou-Bourgade, Caroline Bascoul-Mollevi, et al. · Journal of Clinical Oncology · 501
PDF
Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
2017 · Timothy M Nywening, Brian A Belt, et al. · Gut · 494
Irinotecan: 25 years of cancer treatment
2019 · Christian Bailly · Pharmacological Research · 456
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
2019 · Mark J. Truty, Michael L. Kendrick, et al. · Annals of Surgery · 436
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 · Vanja Vaccaro, Isabella Sperduti, et al. · New England Journal of Medicine · 428
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
2018 · Georgios Gemenetzis, Vincent P. Groot, et al. · Annals of Surgery · 403
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
2022 · Paula Ghaneh, Daniel Palmer, et al. · ˜The œLancet. Gastroenterology & hepatology · 338
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
2019 · Ramesh K. Ramanathan, Shannon L. McDonough, et al. · Journal of Clinical Oncology · 335
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2016 · Davendra P.S. Sohal, Pamela B. Mangu, et al. · Journal of Clinical Oncology · 332
NCCN Guidelines Updates: Pancreatic Cancer.
2019 · Margaret A Tempero · PubMed · 328
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
2025 · Zachary Sethna, Pablo Guasp, et al. · Nature · 326
Works count: 4,108
Citation count: 65,970
Year
Topic
Type